Klinik und Poliklinik für Onkologie
The main field of our research is the development of innovative treatment modalities for cancer patients. By eliciting cell-mediated immune responses we aim at inducing specific immunity against tumor cells. This program consists of 3 major topics, including clinical trials activities, direct assessment of tumor reactive T lymphocytes and molecular biology/SEREX-based antigen discovery. Our institute is affiliated with the Ludwig Institute for Cancer Research (http://www.licr.org) and the Cancer Research Institute (http://www.cancerresearch.org). Both institutes have initiated an international cancer vaccine program that aims at the transition of discoveries from the laboratory in the clinic and is embedded in a collaborative academic environment. We are currently initiating clinical trials within this program. There is a close collaboration to Dr. Jäger at the Krankenhaus Nordwest, Frankfurt (http://www.krankenhaus-nordwest.de/nwk/fk_med_klinik_2.htm). Please contact our website (http://www.dim.unizh.ch/onkolog/index.htm) to get further information on these research activities.